Indo Us Biotech Limited

NSE: INDOUS

23

total announcements

INDOUS.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 20 Oct 2026

Market Cap

₹143 Cr

P/E (TTM)

12.5

EPS (TTM)

₹5.70

52W Low

₹70.00

52W High

₹159.00

Dividend Yield

0.00%

Beta

0.27

Price / Book

1.5

Debt / Equity

40.0

Revenue (TTM)

₹113 Cr

Gross Margin

25.28%

Operating Margin

11.57%

NSEShareholders meeting4 Jul 2026

Indo Us Biotech Limited

Shareholders meeting

Indo Us Biotech Limited has informed the Exchange regarding Notice of Postal Ballot, where the company proposes to obtain the consent of the shareholders by way of Postal Ballot for the matters as considered in the Resolution appended below.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults3 Jul 2026

Indo Us Biotech Limited

Outcome of Board Meeting

Indo Us Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on July 03, 2026. The Board of Directors has decided to seek consent of the Members of the Company by way of Special Resolution through Postal Ballot process for Regularization of appointment of Mrs. Hemanshi Darsh Soni as an Non Executive Independent Director of the Company for a term of five consecutive years. The Board has also approved the appointment of M/s. Bhagat & Associates, Chartered Accountants as Statutory Auditors of the Company with effect from 16 June 2026, subject to approval of the shareholders of the Company.

Read more →📎 1 attachment
NSETrading Window29 Jun 2026

Indo Us Biotech Limited

Trading Window

Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Read more →📎 1 attachment
← PreviousPage 2 of 2